Physician

Benjamin David Spirn, MD

According to 2025 Medicare claims, Benjamin Spirn, MD (NPI: 1417941592) practices ophthalmology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is GARDEN STATE RETINA ASSOCIATES LLC (NPI: 1003960287) and primary practice location at 07702-4178.

Spirn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 953 traditional Medicare patients, billed 887,391 HCPCS/CPT codes, and received $3,559,862 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 293 prescription claims across 91 beneficiaries totaling $25,695 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 25 records totaling $634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,045,937 to $3,559,862. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $2,045,937 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,972,361 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,131,989 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,362,223 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,220,408 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,060,709 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,179,864 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,301,746 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,842,284 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,559,862 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201587216,913$2,045,937
201688915,972$1,972,361
201785217,034$2,131,989
201885317,178$2,362,223
201982016,076$2,220,408
202078812,412$2,060,709
202179813,126$2,179,864
202283616,949$2,301,746
202396145,016$2,842,284
2024953887,391$3,559,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$51K2015 Drug cost: $35,589 (USD; Tot_Drug_Cst)2016 Drug cost: $43,326 (USD; Tot_Drug_Cst)2017 Drug cost: $35,585 (USD; Tot_Drug_Cst)2018 Drug cost: $50,657 (USD; Tot_Drug_Cst)2019 Drug cost: $49,695 (USD; Tot_Drug_Cst)2020 Drug cost: $43,719 (USD; Tot_Drug_Cst)2021 Drug cost: $51,336 (USD; Tot_Drug_Cst)2022 Drug cost: $48,564 (USD; Tot_Drug_Cst)2023 Drug cost: $38,200 (USD; Tot_Drug_Cst)2024 Drug cost: $25,695 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128464$35,589
2016134511$43,326
2017104415$35,585
2018122484$50,657
2019104389$49,695
202087337$43,719
202192378$51,336
2022105421$48,564
202392341$38,200
202491293$25,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system8742,519$104
67028Injection of drug into eye3491,902$102
92134Imaging of retina9302,889$36
92202Extended exam of the back part of the eye with optic nerve drawing8582,494$13
J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg256835,200$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1073,322$3,926
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol201,105$2,935
Atropine SulfateAtropine Sulfate371,383$1,149
MoxifloxacinMoxifloxacin Hcl34456$701

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$634Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Benjamin David Spirn, MD?

Tedicare shows public-source Medicare data for Benjamin David Spirn, MD (NPI 1417941592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin David Spirn, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin David Spirn, MD?

Benjamin David Spirn, MD is linked to GARDEN STATE RETINA ASSOCIATES LLC (billing NPI 1003960287) in the available physician profile data.

Does Benjamin David Spirn, MD have Open Payments data?

Benjamin David Spirn, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.